Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03978598 · ClinicalTrials.gov registry record · Phase 4
Breastfeeding Etonogestrel Implant Study
A Phase 4 study, sponsored by University of New Mexico.
- Completed
- Registry status
- Phase 4
- Development phase
- 150
- Enrollment target
NCT03978598 is a Phase 4 study that has completed, run by University of New Mexico. The registered enrollment target is 150 participants.
The verdict
NCT03978598, a Phase 4 study, has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 150 participants
- Enrollment target
Study Summary
The investigators are studying the effect of placing the etonogestrel implant (Nexplanon) in the first 24 hours after birth on breastfeeding. Women who wish to have an etonogestrel implant placed after their birth, wish to breastfeed, and are willing to participate in the study will be randomly assigned to either get the implant placed in the first 24 hours after delivery of the baby and placenta or 4-6 weeks later. The investigators do not believe there will be a difference in breastfeeding 8 weeks after delivery or time to lactogenesis between those who get the implant placed early or later.
Interventions
- DRUG Etonogestrel
- DEVICE Nexplanon
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-06-03 |
| Est. Completion | 2024-09-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03978598
The ClinicalTrials.gov registry entry for NCT03978598 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of New Mexico, which has 168 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Etonogestrel is the first listed.
NCT03978598 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03978598 about?
NCT03978598 is a clinical study titled "Breastfeeding Etonogestrel Implant Study". The investigators are studying the effect of placing the etonogestrel implant (Nexplanon) in the first 24 hours after birth on breastfeeding. Women who wish to have an etonogestrel implant placed after their birth, wish to breastfeed, and are willing to participate in the study will be randomly assi...
What is the current status of trial NCT03978598?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 150 participants. The study started on 2019-06-03. Estimated completion is 2024-09-19.
What interventions are being tested in trial NCT03978598?
The interventions under investigation include: Etonogestrel (DRUG), Nexplanon (DEVICE).
Who is sponsoring clinical trial NCT03978598?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.